You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

San Antonio, Texas 78229

  • Diabetes Mellitus, Type 2


The purpose of this study is to learn more about how muraglitazar lowers blood sugar in people with type 2 diabetes. The safety of this treatment will also be studied.


Inclusion Criteria: - Type 2 diabetes; - Serum triglyceride concentration < or = 600 mg/dL; - Body mass index < or = 37 kg/m2 Exclusion Criteria: - Type 1 diabetes; - History of myocardial infarction (MI), coronary angioplasty, bypass graft(s), valvular disease, unstable angina pectoris, transient ischemic attack (TIA), or cerebrovascular accident (CVA) within 6 months; - Congestive heart failure (NYHA Class III and IV); - Uncontrolled hypertension; - Women of Child Bearing Potential - History of renal disease, peripheral vascular disease (PVD), pulmonary disease, gastrointestinal disease, active liver disease, or endocrine disease



Primary Contact:


Backup Contact:


Location Contact:

San Antonio, Texas 78229
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.